3Chang S,Sievert DM,Hegeman JC, et al. Infection with vancomycin resistant Staphylococcus aureus containing the vanA resistant gene.N Engl J Med, 2003,384(14): 1342-1347.
4Tenover FC,Weigel LM,Appelbaum PC,et al.Vancomycin-resistant staphylococcus aurens isolate from a patient in Pensylvania.Antimicrob Agents Chemother,2004,48(1 ):275-280.
5Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of staphylococcus aureus heterogeneously resistant to vancomycin.Lancet, 1997,350:1670-1673.
6Hiramatsu K.Vancomycin-resistant staphylococcus aureus : a new model of antibiotic resistance.Lancet Infect Dis,2001,1 : 147-155.
7Cui LX, Ma K, Sato K, et al. Cell wall thickening is a common feature of vancomycin resistance in staphylococcus aureus.J Clin Microbiol,2003,41:5-14.
8Sieradzki K,Tomasz A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutant of staphylococcus aureus. J Bacterial, 1999,181 (24):7566-7570.
9Moore MR,Perdreau-Remington F, Chambers HF.Vancomycin treatment failure associated with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother,2003,47:1262-1266.
10Benquan W, Yingchun T, Kouxing Z, et al.Staphylococcus heterogeneously resistant to vancomycin in China and antimicrobial activities of Imipenem and vancomycin in combination against it. J Clin Microbiol,2002,40(3):1109-1112.
2Tenover FC. Implacations of vancomycin-resistant Staphylococcus aureus. J Hosp Infect, 1999,43 Suppl:3-7.
3Sieradzki K, Pinho M G, Tomasz A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J Bacteriol, 1999,181: 7566-7570.
4Tenover FC, Mohammed MJ, Stelling J, et al. Proficiency testing and quality control results from the World Health Organizations extermal quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol,2001,39 :241-250.
5Sieradzki K, Roberts RB, Serur D, et al. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J Clin Microbiol, 1999,37:39-44.
6Ploy MC, Grelaud C, Martin C, et al. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.Lancet, 1998,351:1212.
7Wong SS, Ho PL, Woo PC, et al. Bacteremia caused by staphylococci with inducibile vancomy. cin heteroresestance. Clin Infect Dis, 1999,24:760-767.
8Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 1997,350:1670-1673.
9Fridkin SK. Vancomycin-intermediate and-resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis,2001,32:108-115.
10Kim MN, Pai CH, Woo JH, et al. Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol, 2000, 38: 3879-3881.
